Related references
Note: Only part of the references are listed.A 6-month randomized, double-blind, placebo-controlled trial of weekly exenatide in adolescents with obesity
D. Weghuber et al.
PEDIATRIC OBESITY (2020)
A Randomized, Controlled Trial of Liraglutide for Adolescents with Obesity
Aaron S. Kelly et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
Hypothalamic Obesity: Prologue and Promise
M. Jennifer Abuzzahab et al.
HORMONE RESEARCH IN PAEDIATRICS (2019)
A randomized pilot efficacy and safety trial of diazoxide choline controlled-release in patients with Prader-Willi syndrome
Virginia Kimonis et al.
PLOS ONE (2019)
Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial
Patrick M. O'Neil et al.
LANCET (2018)
New outlook on the diagnosis, treatment and follow-up of childhood-onset craniopharyngioma
Hermann L. Mueller et al.
NATURE REVIEWS ENDOCRINOLOGY (2017)
Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial
Christopher Sorli et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
GLP-1 receptors exist in the parietal cortex, hypothalamus and medulla of human brains and the GLP-1 analogue liraglutide alters brain activity related to highly desirable food cues in individuals with diabetes: a crossover, randomised, placebo-controlled trial
Olivia M. Farr et al.
DIABETOLOGIA (2016)
A 52-week pilot study of the effects of exenatide on body weight in patients with hypothalamic obesity
Jefferson P. Lomenick et al.
OBESITY (2016)
Glucagon-Like Peptide-1 Excites Firing and Increases GABAergic Miniature Postsynaptic Currents (mPSCs) in Gonadotropin-Releasing Hormone (GnRH) Neurons of the Male Mice via Activation of Nitric Oxide (NO) and Suppression of Endocannabinoid Signaling Pathways
Imre Farkas et al.
FRONTIERS IN CELLULAR NEUROSCIENCE (2016)
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management
Xavier Pi-Sunyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Semiquantitative analysis of hypothalamic damage on MRI predicts risk for hypothalamic obesity
Christian L. Roth et al.
OBESITY (2015)
Hypothalamic Obesity in Craniopharyngioma Patients: Disturbed Energy Homeostasis Related to Extent of Hypothalamic Damage and Its Implication for Obesity Intervention
Christian L. Roth
JOURNAL OF CLINICAL MEDICINE (2015)
GLP-1 Receptor Activation Modulates Appetite- and Reward-Related Brain Areas in Humans
Liselotte van Bloemendaal et al.
DIABETES (2014)
The arcuate nucleus mediates GLP-1 receptor agonist liraglutide-dependent weight loss
Anna Secher et al.
JOURNAL OF CLINICAL INVESTIGATION (2014)
Treatment of Hypothalamic Obesity with Caffeine and Ephedrine
Frank Greenway et al.
Endocrine Practice (2013)
GLP-1 analogues as a new treatment option for hypothalamic obesity in adults: report of nine cases
Flavius Zoicas et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2013)
Childhood Craniopharyngioma: Hypothalamus-Sparing Surgery Decreases the Risk of Obesity
E. Elowe-Gruau et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Glucagon-Like Peptide-1 Agonist Exendin-4 Leads to Reduction of Weight and Caloric Intake in a Rat Model of Hypothalamic Obesity
Clinton T. Elfers et al.
HORMONE RESEARCH IN PAEDIATRICS (2012)
Treatment with Glucagon-Like Peptide-1 Agonist Exendin-4 in a Patient with Hypothalamic Obesity Secondary to Intracranial Tumor
Jill H. Simmons et al.
HORMONE RESEARCH IN PAEDIATRICS (2012)
Hypothalamic obesity in children
A. Bereket et al.
OBESITY REVIEWS (2012)
Post-operative hypothalamic lesions and obesity in childhood craniopharyngioma: results of the multinational prospective trial KRANIOPHARYNGEOM 2000 after 3-year follow-up
Hermann L. Mueller et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2011)
Hypothalamic Obesity in Patients with Craniopharyngioma: Profound Changes of Several Weight Regulatory Circuits
Christian L. Roth
Frontiers in Endocrinology (2011)
Hypothalamic Obesity after Craniopharyngioma: Mechanisms, Diagnosis, and Treatment
Robert H. Lustig
Frontiers in Endocrinology (2011)
Hypothalamic Obesity following Craniopharyngioma Surgery: Results of a Pilot Trial of Combined Diazoxide and Metformin Therapy
Jill K. Hamilton et al.
INTERNATIONAL JOURNAL OF PEDIATRIC ENDOCRINOLOGY (2011)
Insulin sensitivity and secretion in children and adolescents with hypothalamic obesity following treatment for craniopharyngioma
Judith Simoneau-Roy et al.
CLINICAL ENDOCRINOLOGY (2010)
Effects of Exenatide and Lifestyle Modification on Body Weight and Glucose Tolerance in Obese Subjects With and Without Pre-Diabetes
Julio Rosenstock et al.
DIABETES CARE (2010)
Childhood craniopharyngioma-current concepts in diagnosis, therapy and follow-up
Hermann L. Mueller
NATURE REVIEWS ENDOCRINOLOGY (2010)
Blood pressure in children with chronic kidney disease - A report from the Chronic Kidney Disease in children Study
Joseph T. Flynn et al.
HYPERTENSION (2008)
Impact sibutramine therapy in children with hypothalamic obesity or obesity with aggravating syndromes
Pernilla Danielsson et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
被撤回的出版物: Glucagon-like peptide 1 stimulates hypothalamic proopiomelanocortin neurons (Retracted article. See vol. 31, pg. 8698, 2011)
Xiaosong Ma et al.
JOURNAL OF NEUROSCIENCE (2007)
Mechanisms linking obesity with cardiovascular disease
Luc F. Van Gaal et al.
NATURE (2006)
Leptin action in the forebrain regulates the hindbrain response to satiety signals
GJ Morton et al.
JOURNAL OF CLINICAL INVESTIGATION (2005)
Octreotide therapy of pediatric hypothalamic obesity: A double-blind, placebo-controlled trial
RH Lustig et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
The contribution of fat and fat-free tissue to body mass index in contemporary children and the reference child
JCK Wells et al.
INTERNATIONAL JOURNAL OF OBESITY (2002)
Waist circumference and waist-to-height ratio are better predictors of cardiovascular disease risk factors in children than body mass index
SC Savva et al.
INTERNATIONAL JOURNAL OF OBESITY (2000)
Share Paper
